Spirulina platensis and its ingredient biopterin glucoside improved insulin sensitivity in non-alcoholic steatohepatitis model. - GreenMedInfo Summary
and its ingredient biopterin glucoside improved insulin sensitivity in non-alcoholic steatohepatitis model.
J Clin Biochem Nutr. 2021 Sep ;69(2):151-157. Epub 2021 Mar 25. PMID: 34616107
Yuri Fujihara
Non-alcoholic steatohepatitis is the chronic liver disease leading to cirrhosis and cancer and its prevalence is increasing. Some agents are under clinical trials for non-alcoholic steatohepatitis treatment. We previously reportedeffectively prevented non-alcoholic steatohepatitis progression in our model rats. The contribution of phycocyanin, an ingredient of, was limited. We, therefore, have looked for more active components of. In this study, we pursued the effect of biopterin glucoside, another bioactive ingredient of. We foundand biopterin glucoside oral administrations effectively alleviated oxidative stress, inflammation and insulin signal failure, and prevented fibroblast growth factor 21 gene overexpression in non-alcoholic steatohepatitis rat livers. We concluded biopterin glucoside is a major component ofaction.